RESUMEN
Background: Ectopic pregnancy is one of the most important causes of maternal mortality and morbidity in the first trimester of pregnancy. Objective of this study was to compare the safety, feasibility and advantage of laparoscopic approach with that of laparotomy in management of ectopic pregnancy.Methods: A retrospective study was conducted at two tertiary hospitals over a period of two years i.e.; from Aug 2015 to July 2017. Seventy-five patients who had histopathology confirmed tubal ectopic pregnancy were divided into two groups; laparoscopy (Group I, no-39) and laparotomy (Group II no-36). The main outcome measures were operative time, blood loss, and requirement of blood transfusion, requirement of analgesia and duration of hospital stay.Results: Seventy-five patients of ectopic pregnancy who were managed surgically were studied. There were 39 cases in laparoscopy group and 36 cases in laparotomy group. The incidence of ectopic pregnancy was 1.56% (out of all deliveries over 2 years). Ampullary region was the commonest site of ectopic pregnancy (74.6%). No difference was found in the two groups regarding age, site of tubal pregnancy, pre op Hb status and haemoperitoneum. Mean operating time was significantly shorter in the laparoscopy group 39 min (range 30 - 52 min) versus 50 min (range 40-60 min) in the laparotomy group. There was no difference between the groups regarding the treatment with blood products and perioperative complications. Hospital stay was significantly longer in the laparotomy group (3.5 days) as compared to 2 days in laparoscopy group. The duration of post op analgesia requirement was also longer in laparotomy group (4 days) as compared to 2 days in laparoscopy group.Conclusions: Laparoscopic management of ectopic pregnancy is a safe, effective and beneficial option in the hands of an experienced laparoscopic surgeon even in cases of massive haemoperitoneum. It definitely offers the advantage of shorter duration of surgery, faster post op recovery, shorter duration of hospital stays and lesser requirement of post op analgesia.
RESUMEN
Objetivo: Describir el comportamiento biológico del CA 19-9 en colestasis para determinar su utilidad para el diagnóstico de cáncer pancreatobiliar en pacientes con ictericia de origen obstructivo. Sede: Hospital General de México, O.D. Diseño: Prospectivo, longitudinal y comparativo. Análisis estadístico: prueba t y Kolmogorov-Smirnov para muestras independientes; prueba de valor diagnóstico (sensibilidad, especificidad y valor global). Se realizó análisis con curvas ROC para identificar sensibilidad y especificidad con los diferentes puntos de corte. Pacientes y métodos: Se incluyeron 54 pacientes con diagnóstico de ictericia de origen obstructivo. Se dividieron en dos grupos de acuerdo al diagnóstico final, enfermedad maligna vs enfermedad benigna. Se realizó determinación sérica de CA 19-9 al ingreso y al resolver la colestasis y se correlacionaron los niveles con el diagnóstico final. Resultados: En pacientes ictéricos, con un punto de corte de 60 U/mL para distinguir entre enfermedad maligna y benigna, el CA 19-9 tiene una sensibilidad de 80% y una especificidad de 90%. Una vez resuelta la colestasis con punto de corte de 39 U/mL se obtiene una sensibilidad de 71% con una especificidad de 96%. La normalización del marcador después del drenaje biliar es altamente sugerente de patología benigna. La persistencia de niveles elevados (mayores de 60 U/mL) es altamente sugerente de malignidad con una sensibilidad de 58% y especificidad de 100%. Conclusiones: La colestasis sí modifica la sensibilidad y especificidad del CA 19-9 para el diagnóstico de neoplasias malignas pancreatobiliares, por lo que en presencia de ictericia de origen obstructivo el punto de corte de 60 U/mL ofrece una sensibilidad de 80% con una especificidad de 90% para distinguir entre enfermedad benigna y maligna. Una vez resuelta la colestasis, la persistencia de niveles elevados es altamente sugerente de malignidad.
Objective: To describe the biological behavior of the tumor marker CA 19-9 in cholestasis to determine its usefulness for the diagnosis of pancreatobiliary cancer in patients with obstructive-origin jaundice. Sede: General Hospital of Mexico, third level health care center. Mexico City. Design: Prospective, longitudinal, and comparative study. Statistical analysis: T and Kolmogorov Smirnov tests for independent samples; diagnostic value test (sensitivity, specificity, and global value). Analysis with ROC curves was performed to identify sensitivity and specificity at the different cutting points. Patients and methods: We included 54 patients with a diagnosis of obstructive-origin jaundice. They were divided in two groups according to the final diagnosis, malignant disease vs. benign disease. Serum CA 19-9 was determined at admittance and once cholestasis had been resolved, and the levels were correlated with the final diagnosis. Results: In jaundice patients, with a cut point of 60 U/mL to distinguish between malignant and benign disease, the CA 19-9 marker has a sensitivity of 80% and a specificity of 90%. Once cholestasis had been resolved with a cut point of 39 U/mL, sensitivity was of 71% with a 96% specificity. Normalization of the marker after bile drainage is highly suggestive of benign pathology. The persistence of high levels (higher than 60 U/mL) is highly suggestive of malignancy with a sensitivity of 58% and specificity of 100%. Conclusions: Cholestasis does modify the sensitivity and specificity of the CA 19-9 marker for the diagnosis of pancreatobiliary malignant neoplasms; therefore, in the presence of obstructive-origin jaundice, the 60 U/mL cut point offers a sensitivity of 80% with a specificity of 90% to be able to distinguish between malignant and benign disease. Once cholestasis has been resolved, persistence of high levels is highly suggestive of malignancy.